Skip to main content

Table 2 Stage-specific predictive performance metric of the index classifier against the reference standard (TNM stage) (N = 1375)

From: Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database

Metric (95% CI)

I

II

III

IV

Sensitivity

0.99 (0.98, 0.99)

0.82 (0.75, 0.89)

0.64 (0.55, 0.74)

0.92 (0.88, 0.95)

Specificity

0.94 (0.92, 0.96)

0.97 (0.96, 0.98)

0.99 (0.99, 0.99)

0.98 (0.97, 0.99)

Positive predictive value

0.97 (0.97, 0.98)

0.74 (0.67, 0.81)

0.96 (0.91, 0.99)

0.88 (0.84, 0.93)

Negative predictive value

0.98 (0.96, 0.99)

0.98 (0.97, 0.99)

0.97 (0.96, 0.98)

0.99 (0.98, 0.99)

F1 score

0.98 (0.98, 0.99)

0.78 (0.72, 0.83)

0.77 (0.70, 0.84)

0.90 (0.87, 0.93)

c-statistic

0.97 (0.96, 0.98)

0.90 (0.86, 0.93)

0.82 (0.77, 0.87)

0.95 (0.93, 0.97)